ClinicalTrials.Veeva

Menu

Metacognitive Therapy for Comorbid Insomnia

N

Norwegian University of Science and Technology

Status

Withdrawn

Conditions

Secondary Insomnia

Treatments

Other: waiting list
Behavioral: meta-cognitive therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT00235365
S2005.2.gr

Details and patient eligibility

About

The purpose of this study is to determine the effect of meta-cognitive therapy for insomnia.

Full description

This study is a randomized controlled trial with 50 patients with a psychiatric disorder and insomnia. The patients will be randomized into two groups of 25 patients. The first group receives meta-cognitive therapy, whereas the second group will be assigned to a waiting list control.

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Insomnia secondary to a primary psychiatric disorder

Exclusion criteria

  • substance abuse, psychotic symptoms, suicidal intentions, severe organic disorder or psychiatric disorder where sleep restriction is not advised, organic sleep disorder.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

meta-cognitive therapy
Experimental group
Description:
meta-cognitive therapy
Treatment:
Behavioral: meta-cognitive therapy
waiting list
Active Comparator group
Description:
waiting list control
Treatment:
Other: waiting list

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems